Clinical Trial Update: Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)

View source ↗

Summary

This clinical trial update reports on the efficacy, safety, and adherence of hepatitis C patients treated with Infergen (interferon alfacon-1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Infergen (interferon alfacon-1)

Snippet

Sponsor: Closter Pharma | Conditions: Hepatitis C | Status: UNKNOWN